Thomas W Littlejohn

Summary

Publications

  1. ncbi A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring
    T Littlejohn
    Piedmont Research Association, 1901 S Hawthorne Road, Winston Salem, SC 27103, USA
    Can J Cardiol 16:1123-32. 2000
  2. doi Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study
    Thomas W Littlejohn
    Piedmont Medical Research Associates, Winston Salem, NC 27103, USA
    Postgrad Med 121:5-14. 2009
  3. doi Results of treatment with telmisartan-amlodipine in hypertensive patients
    Thomas W Littlejohn
    Piedmont Medical Research Associates, Winston Salem, NC, USA
    J Clin Hypertens (Greenwich) 11:207-13. 2009
  4. ncbi Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension
    Thomas W Littlejohn
    Piedmont Medical Research Associates, Winston Salem, NC 27103, USA
    Curr Med Res Opin 25:951-9. 2009

Detail Information

Publications4

  1. ncbi A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring
    T Littlejohn
    Piedmont Research Association, 1901 S Hawthorne Road, Winston Salem, SC 27103, USA
    Can J Cardiol 16:1123-32. 2000
    ..To compare the antihypertensive efficacy and tolerability of telmisartan 80 mg with valsartan 80 mg throughout a 24 h dosing interval...
  2. doi Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study
    Thomas W Littlejohn
    Piedmont Medical Research Associates, Winston Salem, NC 27103, USA
    Postgrad Med 121:5-14. 2009
    ..An angiotensin receptor blocker (ARB) plus a calcium channel blocker (CCB) seems particularly attractive for these difficult-to-control patients...
  3. doi Results of treatment with telmisartan-amlodipine in hypertensive patients
    Thomas W Littlejohn
    Piedmont Medical Research Associates, Winston Salem, NC, USA
    J Clin Hypertens (Greenwich) 11:207-13. 2009
    ..Peripheral edema was most common in the A10-mg group (17.8%); however, this rate was notably lower when A was used in combination with T: 11.4% (T20/A10), 6.2% (T40/A10), and 11.3% (T80/A10)...
  4. ncbi Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension
    Thomas W Littlejohn
    Piedmont Medical Research Associates, Winston Salem, NC 27103, USA
    Curr Med Res Opin 25:951-9. 2009
    ..This study investigated the safety and efficacy of the direct renin inhibitor aliskiren combined with the calcium channel blocker amlodipine...